TRIMARCO, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 3.024
EU - Europa 524
AS - Asia 278
OC - Oceania 4
AF - Africa 2
SA - Sud America 1
Totale 3.833
Nazione #
US - Stati Uniti d'America 3.019
IT - Italia 247
CN - Cina 230
FI - Finlandia 68
SE - Svezia 61
GB - Regno Unito 58
DE - Germania 56
VN - Vietnam 21
IN - India 17
FR - Francia 10
NL - Olanda 5
CA - Canada 4
IE - Irlanda 4
AU - Australia 3
GR - Grecia 3
JP - Giappone 3
AT - Austria 2
HK - Hong Kong 2
CH - Svizzera 1
CL - Cile 1
DK - Danimarca 1
ES - Italia 1
IL - Israele 1
IR - Iran 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MX - Messico 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PL - Polonia 1
PT - Portogallo 1
RO - Romania 1
RU - Federazione Russa 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 3.833
Città #
Fairfield 505
Chandler 315
Woodbridge 285
Houston 275
Ann Arbor 250
Ashburn 237
Seattle 200
Cambridge 197
Wilmington 180
Padova 76
Helsinki 45
Beijing 43
San Diego 38
Medford 37
Princeton 37
New York 34
Des Moines 33
Guangzhou 32
Nanjing 30
Boardman 29
Dong Ket 20
Jinan 16
Milan 14
Redwood City 12
Shenyang 12
Falls Church 11
Changsha 10
Chicago 8
Hangzhou 8
Nanchang 8
Rome 8
Haikou 7
London 7
Pune 7
Cagliari 6
Jiaxing 6
Paris 6
Phoenix 6
Roxbury 6
Shanghai 6
Turin 6
Hebei 5
Los Angeles 5
Taiyuan 5
Taizhou 5
Zhengzhou 5
Dublin 4
Florence 4
Fuzhou 4
Kilburn 4
Nürnberg 4
Pignone 4
Aprilia 3
Detroit 3
Hefei 3
Hounslow 3
North York 3
Norwalk 3
Tianjin 3
Tokyo 3
Varese 3
Amsterdam 2
Ardea 2
Bologna 2
Borås 2
Casier 2
Cordignano 2
Fermo 2
Gorla Minore 2
Isola della Scala 2
Kochi 2
Kunming 2
Lanzhou 2
Marostica 2
Melbourne 2
New Delhi 2
Ogden 2
Peschiera 2
Piazzola Sul Brenta 2
Portland 2
Redmond 2
Salerno 2
San Francisco 2
San Giovanni Valdarno 2
San Vendemiano 2
Sesto San Giovanni 2
Tappahannock 2
Thessaloniki 2
Valdagno 2
Vienna 2
Washington 2
Wuhan 2
Acton 1
Adelfia 1
Ahmedabad 1
Alghero 1
Ankara 1
Atlanta 1
Avenel 1
Baotou 1
Totale 3.214
Nome #
Direct Pharmacological Targeting of a Mitochondrial Ion Channel Selectively Kills Tumor Cells In Vivo 188
Mitochondrial apoptosis is induced by Alkoxy phenyl-1-propanone derivatives through PP2A-mediated dephosphorylation of Bad and Foxo3A in CLL 183
Targeted activation of the SHP-1/PP2A signaling axis elicits apoptosis of chronic lymphocytic leukemia cells 160
HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia 160
Dominant cytotoxic NK cell subset within CLPD-NK patients identifies a more aggressive NK cell proliferation 157
Major infections, secondary cancers and autoimmune diseases occur in different clinical subsets of chronic lymphocytic leukaemia patients 144
Cortactin, another player in the Lyn signaling pathway, is overexpressed and alternatively spliced in leukemic cells from patients with B-cell Chronic Lymphocytic Leukemia. 142
Abnormal regulation of BCR signalling by c-Cbl in chronic lymphocytic leukaemia 138
Profiling B cell chronic lymphocytic leukemia by reverse phase protein array: Focus on apoptotic proteins 136
Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia 124
Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia 124
Lyn sustains oncogenic signaling in chronic lymphocytic leukemia by strengthening SET-mediated inhibition of PP2A. 122
Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival 120
Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cells. 120
Early effects of the antineoplastic agent salinomycin on mitochondrial function 119
Role of Nocodazole on the survival of chronic lymphocytic leukemia B cells 118
Leukaemic cells from chronic lymphocytic leukaemia patients undergo apoptosis following microtubule depolymerization and Lyn inhibition by nocodazole. 112
In Chronic Lymphocytic Leukemia the JAK2/STAT3 Pathway Is Constitutively Activated and Its Inhibition Leads to CLL Cell Death Unaffected by the Protective Bone Marrow Microenvironment 109
Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments 108
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia 106
Enhanced Chemokine Receptor Recycling and Impaired S1P1 Expression Promote Leukemic Cell Infiltration of Lymph Nodes in Chronic Lymphocytic Leukemia 106
Biophysical Characterization and Expression Analysis of Kv1.3 Potassium Channel in Primary Human Leukemic B Cells 91
HS1, a Lyn Kinase Substrate, Is Abnormally Expressed in B-Chronic Lymphocytic Leukemia and Correlates with Response to Fludarabine-Based Regimen. 91
Lyn-mediated procaspase 8 dimerization blocks apoptotic signaling in B-cell chronic lymphocytic leukemia. 91
Targeting Brutons Tyrosine Kinase in Chronic Lymphocytic Leukemia at the Crossroad between Intrinsic and Extrinsic Pro-survival Signals 81
Ibrutinib in relapsed hairy cell leukemia variant: a case report and review of the literature 79
Increased Survival and Migration of CLL B-Cells in the Presence of Marrow Mesenchymal Stromal Cells: Novel Findings for Microenvironment-Targeted Therapies 78
CLL patients carrying 13q deletion show clinical heterogenity according to IGVH mutational status and CD38 expression 71
Effect of a novel nutraceutical combination on serum lipoprotein functional profile and circulating PCSK9 66
Treatment Induced Cytotoxic T-Cell Modulation in Multiple Myeloma Patients 62
The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cells 61
Phosphorylation of PP2A by Lyn is a key phenomenon in the cancer phenotype of B-CLL 60
B cells from Chronic Lymphocytic Leukemia undergo apoptosis following microtubule depolymerization by nocodazole 55
Vitamin D prevents pancreatic cancer-induced apoptosis signaling of inflammatory cells 51
Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic Leukemia 50
Leukemic cell from B-CLL patients display heterogeneous response to the anti-apoptotic effect of mesenchymal stromal cells 45
CLL patients with low-risk cytogenetic abnormalities show clinical heterogeneity according to IGVH mutational status and CD38 expression 44
Hypocellular myelodysplastic syndromes (h-MDS): from clinical description to immunological characterization in the Italian multi-center experience 19
Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study 17
Persistent splenomegaly due to littoral cell angiomatosis in venetoclax-induced undetectable minimal residual disease of chronic lymphocytic leukemia 11
Focal adhesion kinase activation by calcium-dependent calpain is involved in chronic lymphocytic leukaemia cell aggressiveness 9
Pro-inflammatory cells sustain leukemic clonal expansion in T-cell large granular lymphocyte leukemia 3
Totale 3.931
Categoria #
all - tutte 13.308
article - articoli 12.936
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.244


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019193 0 0 0 0 0 0 0 0 0 0 104 89
2019/2020853 79 41 10 96 78 52 72 102 89 124 77 33
2020/2021734 47 37 45 68 26 19 23 65 73 196 91 44
2021/2022647 21 44 64 73 74 44 35 73 43 7 30 139
2022/2023605 93 67 19 100 82 62 16 37 72 6 40 11
2023/2024399 25 51 42 33 48 77 31 47 13 32 0 0
Totale 3.931